Cytokine Activation and Disease Progression in Patients With Stable Moderate Chronic Heart Failure

CRP may be used as a surrogate parameter for interleukin-6 and complement activation in moderate CHF. CRP in combination with BNP identifies a high-risk group with a tendency for poor outcome not discriminated by cardiac function.